Abstract
Granular corneal dystrophy type 2 (GCD2) is an autosomal dominant disease affecting vision. Phototherapeutic keratectomy (PTK) is advantageous in removing vision-threatening corneal opacities and postponing keratoplasty; however, it potentially disturbs accurate intraocular lens (IOL) power calculation in cataract surgery. The myopic/hyperopic Haigis-L method with or without the central island has been reported; nevertheless, an optimal method has not yet been established. To compare the predictive accuracy of post-PTK IOL power calculations in GCD2, the retrospective data of 30 eyes from July 2017 to December 2020 were analyzed. All GCD2-affected eyes underwent post-PTK standard cataract surgery using the WaveLight EX500 platform (Alcon Laboratories, Inc., Fort Worth, TX, USA) under a single surgeon. The mean prediction error (MPE) and absolute error (MAE) with the myopic/hyperopic Haigis-L, Barrett Universal II, Barrett True-K, Haigis, and SRK/T by standard keratometry (K) and total keratometry (TK), where possible, were analyzed. Barrett Universal II and SRK/T showed significantly superior MPE, and MAE compared with the myopic/hyperopic Haigis-L method. TK was not significantly superior to K in the same formula. In conclusion, this study suggests that these biometries and formulas, especially Barrett Universal II and SRK/T, are potentially useful in IOL power calculation in GCD2 after PTK.
Original language | English |
---|---|
Article number | 584 |
Journal | Journal of Clinical Medicine |
Volume | 12 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2023 Jan |
Bibliographical note
Funding Information:This work was supported by a faculty research grant from Yonsei University College of Medicine [grant number 6-2020-0222], the Basic Science Research Program (NRF-2021R1I1A1A01047951) of the National Research Foundation (NRF), and by the Korean Fund for Regenerative Medicine (KFRM) grant (KFRM 22C0615L1) funded by the Korean Government (the Ministry of Science and ICT, the Ministry of Health & Welfare). The funding organization had no role in the design or conduct of this study.
Publisher Copyright:
© 2023 by the authors.
All Science Journal Classification (ASJC) codes
- Medicine(all)